A

Affect Therapeutics

Digital addiction treatment with contingency management

Counselor Supervisor

Full-TimePosted on 10/22/2026
No salary listed
Junior, Mid
Portland, OR, USA
In PersonMust work in-office in the Portland metro area.
Medical, Clinical & VeterinaryMental & Behavioral Health

About the job

Requirements
  • Hold an active, independent Oregon license as an LCSW or LPC.
  • Have at least 2 years of experience as an independent clinician.
  • Have prior experience supervising clinicians.
  • Be able to supervise clinicians across substance use and mental health treatment.
  • Be willing to work in-office in the Portland metro area.
  • Be able to maintain a Monday–Friday schedule.
  • Have experience supporting documentation standards, utilization, and performance management.
  • Be comfortable working in a structured, fast-paced clinical environment.
Responsibilities
  • Provide individual and group clinical supervision to counselors and therapists.
  • Coach clinicians on complex cases, clinical skill development, and adherence to treatment standards.
  • Drive clinical outcomes and team performance, including productivity, engagement, and quality metrics.
  • Monitor and ensure timely documentation, billing accuracy, and compliance standards.
  • Support caseload and utilization management, including scheduling optimization and panel adjustments.
  • Conduct chart reviews, audits, and performance evaluations.
  • Partner with clinical leadership, operations, and medical teams to ensure smooth day-to-day care delivery.
  • Support training, onboarding, and ongoing development of clinicians.
  • Contribute to new program initiatives, protocols, and quality improvement efforts.
  • Maintain a small clinical caseload as needed to support operations and remain connected to care delivery.
  • Participate in hiring and help build a strong, mission-aligned team.
Desired Qualifications
  • Have experience leading teams and managing clinical staff performance.
  • Have experience with hiring, onboarding, or training clinicians.
  • Be familiar with the local Oregon treatment landscape and community resources.

About the company

Affect Therapeutics provides digital addiction recovery services that combine contingency management with therapy and medication. The platform is private, fully online, and accessible via secure video conferencing, removing the need to visit clinics. It uses financial incentives to reward healthy behaviors, helping users build new habits, and offers holistic support such as job search, housing guidance, and bill management to improve overall life circumstances. The business likely operates on a subscription or fee-for-service model to fund ongoing treatment and support. Compared to traditional clinics, the service emphasizes digital convenience, privacy, and integrated life-support, aiming to help people recover from addiction and improve their broader daily life.

Company Size

51-200

Company Stage

Series B

Total Funding

$49M

Headquarters

Tysons, Virginia

Founded

2020

Get referred to Affect Therapeutics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Affect raised $26 million on September 23, 2025 to expand nationally.
  • Its app was updated August 27, 2026 and still advertises Medicare and Medicaid coverage.
  • Affect says it serves over 100 employer, Medicaid, marketplace, and Medicare Advantage plans.

What critics are saying

  • If CMS or states tighten contingency-management reimbursement, Affect's payer model breaks.
  • Commercial insurers can delay contracting; without renewals, growth stalls by 2027.
  • Privacy breaches or low patient retention would undermine trust and trigger rapid member churn.

What makes Affect Therapeutics unique

  • Affect combines contingency management, therapy, and medication in one smartphone clinic.
  • It operates in 20 states and accepts Medicare, Medicaid, and commercial insurance.
  • NIH-backed research and 2025 Series B validation support its clinical model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Sick Leave
  • Remote Work Options
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

2%

1 year growth

2%

2 year growth

1%
U.S. Securities and Exchange Commission
Oct 25th, 2026
EDGAR Filing Documents for 0001883067-21-000001

EIN.: 852224169 | State of Incorp.: DE | Fiscal Year End: 1231Type: D | Act: 33 | File No.: 021-414392 | Film No.: 211271985

Behavioral Health Business
Nov 5th, 2025
Affect Therapeutics Raises $26M Funding

Affect Therapeutics, a digital mental health and addiction treatment provider, has raised $26M in a Series B funding round led by Allumia Ventures. The company offers therapy, medical support, and a gamified app for conditions like depression, PTSD, anxiety, OCD, and substance use disorders. It operates in several U.S. states and accepts major insurance plans. Previously, Affect Therapeutics raised $23M, including a $16M Series A in 2023.

Crunchbase
Jul 13th, 2023
Affect raises $16M as addiction-related financings hold strong

Affect Therapeutics, a provider of all-digital addiction treatment programs, raised $16 million in a Series A round led by Artis Ventures.

FinSMEs
Jul 12th, 2023
Affect Therapeutics Raises $16M In Series A Funding

Affect Therapeutics, a McLean, VA-based company providing addiction treatment for the digital age, raised $16M in Series A funding.The round was led by ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures. Stuart Peterson of ARTIS Ventures has joined the Board, and Dr. Imran Hamid of LifeArc Ventures joined the Board as an observer. The company intends to use the funds to enable national expansion, program expansion, and engineering innovation in the Affect app.Founded in 2020, Affect Therapeutics offers clinically intensive treatment that follows a scientifically-proven program supporting the entire recovery journey via a smartphone app for drug and alcohol addiction. The approach, based on the best research in the field including its own NIH-sponsored studies, combines experts at unlocking behavior change and motivation, with members receiving rewards for success in treatment, including engagement and provision of negative drug and alcohol screens. The company’s approach couples this type of cognitive behavioral therapy with counseling, medical oversight, and case management, delivering a comprehensive program based on decades of research.Affect currently holds outpatient treatment licenses in 20 states and aims to serve a majority of the U.S. population by the end of 2023

Yahoo Finance
Jul 12th, 2023
Delivering Next generation Addiction recovery, Affect Therapeutics raises $16 million in Series A funding led by ARTIS Ventures

Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by TechBio-focused ARTIS Ventures with additional participation from previous investors AlleyCorp and CityLight, as well as new investments from LifeArc Ventures, Samsung Next, and What If Ventures.